Metromile Inc (NASDAQ:MILE) announced an integration with Verisk Analytics, Inc’s (NASDAQ:VRSK) LightSpeed Auto to simplify the consumer buying experience, increase speed to bind…
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.